Sensus Healthcare, Inc. (NASDAQ:SRTS) Issues Quarterly Earnings Results

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its earnings results on Thursday. The company reported ($0.06) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.14) by $0.08, Morningstar.com reports. The firm had revenue of $4.97 million for the quarter, compared to analyst estimates of $4.50 million. Sensus Healthcare had a negative return on equity of 13.02% and a negative net margin of 11.90%.

Sensus Healthcare (NASDAQ:SRTS) traded up 11.67% on Friday, reaching $4.65. The company’s stock had a trading volume of 61,907 shares. Sensus Healthcare has a 12 month low of $3.38 and a 12 month high of $6.69. The stock’s 50 day moving average price is $3.88 and its 200 day moving average price is $4.26. The company’s market cap is $62.90 million.

Several research analysts have weighed in on SRTS shares. Zacks Investment Research lowered Sensus Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, April 6th. Maxim Group started coverage on Sensus Healthcare in a report on Tuesday, June 6th. They set a “buy” rating and a $6.50 target price on the stock.

About Sensus Healthcare

Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.